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Abstract
Kaposi’s sarcoma-associated herpesvirus (KSHV) replication and transcription activator (RTA) is necessary and sufficient for the switch from
KSHV latency to lytic replication. RTA activates promoters by several mechanisms. RTA can bind to sequences in viral promoters and activate
transcription. In addition, RTA interacts with the cellular recombination signal sequence-binding protein-J kappa (RBP-Jκ), a transcriptional repressor, converts the repressor into an activator and activates viral promoters via RBP-Jκ. Because RBP-Jκ is required for RTA to activate lytic
replication, it is important to understand how RTA cooperates with RBP-Jκ protein to activate KSHV lytic replication program. Previously, we
identified an RTA mutant, RTA-K152E, which has a defect in its direct DNA-binding activity. In this report, the effect of the mutant RTA on
KSHV activation via RBP-Jκ protein is examined. We demonstrate that RTA-K152E interacts with RBP-Jκ physically and the mutant RTA and
RBP-Jκ complex binds to target DNA properly in vivo and in vitro. However, the complex of RTA-K152E and RBP-Jκ does not activate transcription. Furthermore, the RTA mutant (RTA-K12E) inhibits cellular Notch-mediated RBP-Jκ activation. These data collectively suggest that
the complex between KSHV RTA and cellular RBP-Jκ and the subsequent DNA binding by the complex are not sufficient for the activation of
RBP-Jκ protein. Other factor(s) whether additional cofactor(s) in the complex or the intrinsic conformation of RTA, are predicted to be required
for the activation of RBP-Jκ protein by RTA.
Keywords: KSHV, RTA, RBP-Jκ, Lytic replication, HHV8, PEL

1. Introduction

(Dourmishev et al., 2003; West and Wood, 2003). RTA is an
immediate early gene (Sarid et al., 1998; Sun et al., 1999;
Zhu et al., 1999) and a sequence-specific DNA-binding protein. A number of RTA-responsive elements (RRE) were identified in the transcriptional regulatory regions of different
subsequently expressed viral genes (Gradoville et al., 2000;
Lukac et al., 1999; Sakakibara et al., 2001; Saveliev et al.,
2002; Sun et al., 1998; Sun et al., 1999; Zhu et al., 1999).
In addition to direct DNA binding, the ability of RTA to interact with other factors appears to be necessary for activating
its transcriptional potential (Gwack et al., 2001; Gwack et al.,
2002; Liao et al., 2003; Wang et al., 2001). One of the interacting factors is the cellular recombination signal sequencebinding protein-J kappa (RBP-Jκ) (also known as CBF-1
and CSL) (Carroll et al., 2006; Liang et al., 2002; Liang and

Kaposi’s sarcoma (KS)-associated herpesvirus (KSHV), also
known as human herpesvirus 8 (HHV-8), is a gamma herpesvirus. It is believed to be the etiological agent of KS (Chang et
al., 1994; Chang and Moore, 1996; Moore and Chang, 2001).
KSHV is also implicated in the pathogenesis of AIDS-associated primary effusion lymphoma (PEL, also called body cavity-based lymphoma (BCBL)) and a lymphoproliferative disorder known as multicentric Castleman’s disease (Dourmishev
et al., 2003; Moore and Chang, 2001; West and Wood, 2003).
As other herpesviruses, KSHV goes through both latency
and lytic replication cycles. The expression of the KSHV
replication and transcription activator (RTA) is necessary
and sufficient for the switch from latency to lytic replication


 

Ganem, 2003). RBP-Jκ is a sequence-specific DNA-binding
protein and a transcriptional repressor that is involved in the
Notch signaling pathway.
The Notch signaling pathway regulates cell fate in a variety of organisms (Bray, 2006; He and Pear, 2003). Interaction
of Notch receptors (Notch) with their ligands leads to cleavage of the Notch intracellular domain (NICD), which leads to
nuclear localization of NICD. In the nucleus, NICD associates
with RBP-Jκ and converts RBP-Jκ from a transcriptional repressor to an activator. Furthermore, the NICD-RBP-Jκ complex activates expression of specific target genes (Bray, 2006;
He and Pear, 2003).
KSHV RTA can directly bind to RBP-Jκ and the RTA–
RBP-Jκ complex binds to DNA and activates transcription of
KSHV promoters (Carroll et al., 2006; Liang et al., 2002; Liang and Ganem, 2003). The KSHV genome contains numerous RBP-Jκ elements suggesting that RBP-Jκ plays an important role in viral transcription. The interaction between RTA
and RBP-Jκ is essential for the switch from viral latency to
lytic replication in rodent cells (Liang and Ganem, 2003).
However, it is not clear if interaction between RTA and RBPJκ is the only event that is necessary for activating KSHV lytic
gene expression.
Previously, we have identified a novel function of RTA, i.e.,
RTA binds to interferon-stimulated response elements (ISRE)
and activate certain cellular interferon-stimulated genes (ISG)
(Zhang et al., 2005). In addition, a region in RTA DNA-binding domain has been identified with certain sequence similarity to the DNA-binding domains of interferon regulatory factor (IRF) family. Mutation in one conserved amino acid within
this region (RTA-K152E) reduces the ability of RTA to bind
to ISRE as well as other RREs. Furthermore, the RTA-K152E
fails to activate RTA-responsive promoters and to induce viral
lytic gene expression (Zhang et al., 2005).
In this report, we have further characterized the RTAK152E mutant in terms of activating the cellular RBP-Jκ protein. The mutant RTA is able to interact with RBP-Jκ physically and the RTA-K152E-RBP-Jκ complex is able to bind to
DNA in vitro and in vivo. However, the mutant failed to activate RBP-Jκ protein. Thus, the complex between KSHV RTA
and cellular RBP-Jκ and their subsequent DNA binding are
not sufficient for the activation of RBP-Jκ protein.
2. Materials and methods
2.1. Plasmids and antibodies
Expression plasmids of FLAG-tagged RTA and mutant RTAK152E were previously described (Zhang et al., 2005). The
HA-tagged RBP-Jκ expression plasmid was a gift from Dr.
Paul Ling (Baylor College of Medicine). FLAG-tagged RBPJκ expression plasmid and the reporter construct containing
3× RBP-Jκ binding site were gifts from Drs. Don Ganem and
Yuying Liang (Liang et al., 2002). The constitutively active
Notch expression plasmid, pcDNA-3-mNotch-ΔE, was a gift
from Dr. Franz Oswald (Oswald et al., 2002). CMV-β-gal and
CMV-GFP expression plasmids were from Clontech. Peptide
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RTA antibody was described (Xu et al., 2007). Tubulin and
FLAG-antibodies were purchased from Sigma. HA and RBPJκ antibodies were purchased from Santa Cruz.
2.2. Western blot analysis, cell culture, transient transfection
and reporter assays
Standard western blot analysis was performed as previously
described (Zhang and Pagano, 1997; Zhang and Pagano, 1999;
Zhang and Pagano, 2000; Zhang and Pagano, 2001). 293-Bac
(a gift from Dr. S.J. Gao) is a human 293 cells derived cell
line and containing KSHV genome (Zhou et al., 2002). 293Bac36 cells were maintained in DMEM plus 10% fetal bovine
serum (FBS) plus 0.5 mg/ml hygromycin. 293T cells are a human fibroblast line and were maintained in DMEM plus 10%
FBS. Effectene (Qiagen) was used for the transfection of these
cells. The luciferase assays were performed using a kit from
Promega according to manufacturer’s recommendation.
2.3. Preparation of KSHV stocks and detection of virion DNA
293-Bac36 cells were transfected with the designated expression plasmids and culture supernatants were harvested 5 days
later. Virions were pelleted by centrifugation at 100,000 × g
for 1 h. The pellets were subsequently suspended in 1× PBS
buffer (1:100 of the volume of the original supernatants). The
concentrated viruses were then treated by DNase I at 37 °C for
1 h. DNA was extracted and PCR analyses were carried out
with primers targeted K14/vGCR region (BC1 KSHV genome
coordinates: 127,649–127,883). The conditions of the PCR assay were established empirically to ensure a linear amplification of template DNA within the amplification conditions.
2.4. Chromatin immunoprecipitation (ChIP)
293-Bac36 cells were transfected with various plasmids. One
day later, ChIP assays were performed using the chromatin
immunoprecipitation assay kits according to the manufacturer’s recommendation (Upstate, Inc.). Anti-FLAG and normal
rabbit serum (NRS) was used as designated. The DNA exacted from immunoprecipitates was used as template for PCR
analyses with various primers that amplify MTA- and PANspecific products (Wang et al., 2003a; Wang et al., 2003b).
PCR products were resolved in 8% polyacrylamide gel.
2.5. Co-immunoprecipitation (Co-IP)
293T cells grown in 10 cm plates were transfected with the
designated plasmids. Cell extracts were prepared using RIPA
buffer (1× PBS, 1% NP-40, 0.5% sodium deoxycholate, 0.1%
SDS) supplemented with a protease inhibitor cocktail (Roche)
were incubated with either mouse anti-FLAG monoclonal antibody M2 (Sigma) or anti-HA antibody (Santa Cruz) for 1 h
on ice. Protein G-sepharose (Pharmacia) was added and the
incubation continued at 4 °C overnight with gentle rotation.
Beads were washed three times with 1× PBS buffer and boiled
in SDS loading buffer and subsequent western blot were essentially the same as described.
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2.6. Electrophoretic mobility shift assay (EMSA)
The probes were obtained by first annealing complementary
oligonucleotides and then labeling them with (α-32P)dCTP
(Amersham) using DNA polymerase Klenow fragment (Fermentas). The RBP-Jκ probe was obtained by annealing two
oligonucleotides, 5′-GATCTGGTGTAAACAC GCCGTGGGAAAAAATTTATG-3′ and its complementary stand,
with GATC at the 5′ end. DNA-binding reactions were performed essentially as described (Liang et al., 2002; Lukac et
al., 2001) with the following modifications: the reaction buffer
contained 10 mM Tris–HCl (pH 7.5), 50 mM NaCl, 5.3 mM
MgCl2, 1 mM EDTA, 1 μg polydIdC and 4% glycerol and the
reactions were carried out at 25 °C for 30 min. If an antibody
was used for a super-shift experiment, 1 μl of the target antibody was added into the reaction mixture.
2.7. In vitro transcription and translation
Proteins were synthesized with the TNT coupled transcription and translation kit with rabbit reticulocyte lysate (Promega) according to the manufacturer’s instructions. pcDNA3RTA and RTA-K152E (Zhang et al., 2005) and FLAG-RBP-Jκ
were used for in vitro transcription and translation of target
proteins. Luc-plasmid was provided by the manufacturer as a
positive control for the kit.
3. Results
3.1. RTA-K152E binds to cellular RBP-Jκ
The RTA-K152E mutant does not bind DNA efficiently in vitro and fails to activate several KSHV promoter reporter constructs or endogenous lytic gene expression (Zhang et al.,
2005). However, it is not known whether RTA-K152E interacts with RBP-Jκ. To test whether RTA-K152E interacts
with RBP-Jκ, plasmids expressing these proteins were transfected into 293T cells and co-immunoprecipitation assays (coIP) were performed. Expression plasmids containing wtRTA,
RTA-K152E and RBP-Jκ were transfected into 293T cells.
The transfected RTA and RBP-Jκ were tagged by FLAG or influenza hemagglutinin (HA) epitope, respectively (see Section
2 for details). As shown in Figure 1, both wtRTA and RTAK152E interacted with RBP-Jκ in co-IP assays. In several experiments, wtRTA and RTA-K152E appeared to interact with
RBP-Jκ with similar efficiency. In addition, RTA interacted
with endogenous RBP-Jκ in co-IP assays (data not shown).
Thus, the RTA-K152E interacted with RBP-Jκ protein in transiently transfected 293T cells.
3.2. RTA-K152E binds to RBP-Jκ site indirectly in vitro
To test whether the complex between RTA-K152E and RBPJκ interacted with DNA, EMSA was performed with an RBPJκ consensus recognition sequence as a probe. The respective
proteins were synthesized to similar levels by in vitro transcription and translation (Figure 2B). The expression of RBPJκ was also confirmed by western blot with the anti-FLAG

Figure 1. RTA-K152E interacts with RBP-Jκ. 293T cells were transfected
with the designated expression plasmids as shown on the top of the figure. Cell
extracts from these transfected cells were immunoprecipitated (IP) with either
anti-HA (panel A) or anti-FLAG (panel B). The immunoprecipitates were analyzed by western blot (WB) using the indicated antibodies. In panel C, whole
cell lysate was used for western blot analyses. The identity of the respective
proteins is denoted.

antibody (data not shown). Various combinations of in vitro
translated proteins were used for EMSA with a RBP-Jκ consensus recognition sequence as probe. As shown in Figure 2,
a specific shifted band representing the RBP-Jκ protein binding to the RBP-Jκ probe was observed (lane 3). The shifted
band was competed for by incubating with 50× of a cold wild
type RBP-Jκ recognition sequence oligonucleotides. In contrast, a mutated RBP-Jκ recognition sequence oligonucleotides did not compete for binding (data not shown). The RTA
or RTA-K152E proteins were unable to bind to the RBP-Jκ
probe directly, which was expected (lanes 4 and 5). Additional
protein–DNA complexes appeared when RTA, or the RTAK152E mutant, was incubated with RBP-Jκ prior to performing EMSA (lanes 6 and 7). This novel DNA–protein complexes were specific because they disappeared in the presence
of a RTA antibody (lanes 8 and 9), but were not affected by
normal rabbit serum (NRS) (lanes 10 and 11). Furthermore,
the complexes were not present when the RTA antibody was
mixed with either RBP-Jκ or RTA individually (lanes 12 and
13). In summary, these results suggested that both wtRTA and
the RTA-K152E mutant were able to interact with the RBPJκ protein and consequently bind as a complex to a consensus
RBP-Jκ recognition site.
3.3. RTA-K152E binds to KSHV DNA in vivo
To test whether a complex between RTA-K152E and RBP-Jκ
forms in vivo and binds DNA, ChIP assays were performed.

 

P apugani

et al . in

V irus R esearch 131 (2008)

Figure 2. RTA-K152E binds to DNA indirectly via RBP-Jκ. (A) RTA-K152E binds to DNA via RBP-Jκ. The RBP-Jκ probe was labeled with (α-32P)-dCTP. In
vitro transcribed and translated proteins were used for EMSA analyses in various combinations as shown on the top of the gel. Normal rabbit serum (NRS) and
rabbit polyclonal anti-RTA were used for blocking the complex formations. Specific protein–DNA complexes are as shown. (B) Expression levels of RTA. Equal
amounts of in vitro transcribed and translated reticulocyte lysates containing RTA and RTA-K152E proteins were used for western blot analyses. The identity of
proteins is as shown. (C) RTA-K152E binds to KSHV genomic DNA in vivo. 293-Bac36 cells were transfected with pcDNA3, RTA or RTA-K152E expression
plasmid. Twenty-four hours later, FLAG antibody was used for ChIP analyses to detect in vivo DNA-binding activities of RTA proteins derived from input plasmids. Primers for MTA and Pan promoter regions were used to amplify the DNA from immunoprecipitates. The identity of DNA is as shown. The genomic DNA
was used as positive control. Input DNA represents the PCR amplification from same amounts of input lysates without immunoprecipitations. PCR amplification
of immunoprecipitates from normal rabbit serum (NRS) is also shown as controls.

The wtRTA or RTA-K152E mutant was transfected into 293Bac36 cells, a human 293 derived cell line harboring the
KSHV genome (Zhou et al., 2002). Expression of the two
RTA proteins was similar (data not shown, also Figure 5B).

Anti-FLAG antibody was used for ChIP analyses because this
approach avoided the endogenous auto-regulation of RTA expression (Deng et al., 2000; Sakakibara et al., 2001). Two
KSHV promoter regions, MTA and PAN, were used as tar-

I nteraction

of

KSHV RTA

with cellular

RBP-Jκ

and activation of

gets for amplifying DNA from the immunoprecipitates as described (Wang et al., 2003a; Wang et al., 2003b). As shown in
Figure 2C, both the MTA and Pan promoter regions were amplified from immunoprecipitates regardless of whether wtRTA
or RTA-K152E was transfected. However, PCR amplification
resulted in the similar amounts of target DNA from the immunoprecipitates by normal rabbit serum (NRS). In addition, input DNA before immunoprecipitations was similar. These results collectively suggested that both wtRTA and RTA-K152E
interacted with KSHV genomic DNA in 293T cells with similar efficiencies, which was in agreement with the EMSA data
(Figure 2A).
3.4. The RTA-K152E does not activate transcription, in spite
of interacting with RBP-Jκ
wtRTA interacts with the RBP-Jκ protein and consequently
activates specific viral promoters (Carroll et al., 2006; Liang et al., 2002; Liang and Ganem, 2003). To test whether
the RTA-K152E mutant was capable of trans-activating viral transcription, the ability of the RTA-K152E mutant to activate a minimal promoter construct containing multiple RBPJκ consensus binding sequences was examined (Liang et al.,
2002). The promoter reporter construct and RTA expression
plasmids were co-transfected into 293T cells and reporter activities measured. As shown in Figure 3A, wtRTA was able
to activate the minimum promoter reporter construct containing RBP-Jκ-binding sites approximately 15-fold in a
dose-dependent fashion. In sharp contrast, the RTAK152E
failed to activate the reporter construct above basal levels.
The mutant RTA was expressed in relatively higher amounts

Figure 3. RTA-K152E fails to activate RBP-Jκ protein. (A) RTA-K152E fails
to activate the RBP-Jκ protein. 293T cells were transfected with 3× RBP-JκLuc reporter constructs along with CMV-β-gal, RTA or RTA-K152E expression plasmids as shown on the top of the panel. Luciferase activity was normalized by β-galactosidase activity. The fold activation of promoter constructs
in response to K-RTA is shown with standard deviations. The results from one
representative experiment in triplicates were shown. (B) Expression levels of
RTA and its mutant. Western blotting with FLAG antibody was performed.
The cell lysate from transfected cells are indicated. The identity of proteins is
as shown. Lane numbers denote the same treatment as shown in panel A.

RBP-Jκ  

than wtRTA (Figure 3B). Because comparable β-galactosidase
activities were observed between wtRTA and the mutant RTA
expressing cells, there was no apparent toxicity associated
with mutant RTA expressed cells. In addition, same results
could be obtained with the similar levels of RTAs by manipulation of transfected plasmid amounts (data not shown). All
these results suggested that RTA-K152E was unable to convert RBP-Jκ protein into a transcriptional activator.
3.5. RTA-K152E interferes intracellular Notch signaling
To test the physical interaction between the mutant RTA and
RBP-Jκ from another direction, we examined if RTA-K152E
affects the Notch signaling pathway. Because RBP-Jκ is involved in the Notch signaling pathway, we suspect that overexpression of the RTA-K152E mutant would alter the Notch
signaling pathway by interacting and sequestering the RBPJκ protein. A constitutive active mutant of Notch was used for
these studies. As shown in Figure 4, the constitutively active
Notch mutant activated the RBP-Jκ reporter construct by at
least 20-fold in a dose-dependent fashion. The expression of
wtRTA-stimulated the RBP-Jκ reporter construct more than
40-fold. The co-expression of wtRTA with activated Notch
did not further stimulate the RBP-Jκ reporter construct activity. Although wtRTA binds to RBP-Jκ but because wtRTA itself activates RBP-Jκ, no effect of wtRTA on Notch signaling
pathway is anticipated. In sharp contrast, the RTA-K152E mutant interfered with the ability of Notch to activate the RBPJκ promoter construct. Due to the fact that mutant RTA interacts with RBP-Jκ, these data suggest that mutant RTA inhibit
the Notch signaling and possibly through sequestering RBPJκ. These data indirectly support the physical interaction between the mutant RTA and RBP-Jκ in vivo.

Figure 4. RTA-K152E interferes intracellular Notch signaling. Various
amounts of constitutively active Notch were transfected into 293T cells with a
fixed amount of the other plasmids as shown on the top of the panel. Luciferase activity was normalized by β-galactosidase activity. The fold activation of
promoter constructs was shown with standard deviations. The results from one
representative experiment in triplicates were shown.

 

Figure 5. RTA-K152E fails to induce KSHV virion production. (A) RTAK152E fails to induce DNase-resistant KSHV genomic DNA packaged into
virions. The media from pcDNA3, RTA or RTA-K152E transfected 293-Bac36
cells were collected and KSHV viruses were concentrated by centrifugation.
After DNase I digestion, PCR analyses were used for detecting KSHV genomic DNA. The genomic DNA isolated from 293-Bac36 was used as positive control. (B) Expression of RTA and its mutant in transfected cells. Lysate
from pcDNA3, RTA, or RTA-K152E transfected 293-Bac36 cells were used
for western blot analysis with FLAG and tubulin antibodies. The identity of
the respective proteins is denoted.

3.6. RTA-K152E fails to induce KSHV virion production
We have previously shown that RTA-K152E fails to activate
KSHV lytic genes through direct DNA binding (Zhang et al.,
2005). In this report, data in Figure 3 and Figure 4 suggested
that RTA-K152E would not activate genes mediated by RTA–
RBP-Jκ-complex through an indirect DNA-binding mechanism. Because RTA activates viral promoters through both
direct and indirect DNA-binding mechanism, it is thus necessary to directly test if the mutant fails to induce a complete
KSHV lytic replication. KSHV virion production is the final
step of the lytic replication and we thus measured the production of the virions in response to RTA expression. The expression plasmid of wtRTA or RTA-K152E mutant was transfected
into 293-Bac36 cells (Zhou et al., 2002). The expression levels of RTAs were similar in cell lysates (Figure 5B). The media were collected 5 days later and virus particles in the media
were concentrated and digested by DNase. Semi-quantitative PCR was subsequently used to detect the DNase-resistant KSHV genomic DNA packaged in virions. The condition
of the PCR was established empirically for a linear amplification of template DNA. As expected, wtRTA induced the accumulation of DNase-resistant KSHV genomic DNA (Figure 5A). In contrast, DNase-resistant genomic DNA was not
detected following transfection of 293-Bac36 cells with the
RTA-K152E mutant. Thus, RTA-K152E mutant was unable to
induce KSHV virion production.
4. Discussion
Numerous studies have indicated that RTA activates target
promoters by directly binding to DNA and by indirectly binding via interaction with various cellular factors (Dourmishev
et al., 2003; West and Wood, 2003). RBP-Jκ plays an essen-
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tial role in RTA-mediated KSHV lytic replication. In this report, we have addressed whether the RTA-RBP-Jκ interaction
is sufficient for the lytic replication of KSHV.
Notch signaling is well conserved in evolution. Many viruses usurp this signaling pathway for their own benefits
(Hayward, 2004). However, none of them, including KSHV,
can be completely replaced by cellular Notch signaling
(Chang et al., 2005). RTA must have its own specific properties to usurp Notch signaling pathway. RTA-K152E has a
mutated DNA-binding domain and has a defect in its direct
DNA-binding activity as determined by EMSA with the purified protein. Like wtRTA, RTA-K152E interacted with RBPJκ physically and the mutant–RBP-Jκ complex was able to
bind to DNA (Figure 1 and Figure 2). However unlike the
wtRTA, the physical interaction between the RTA mutant and
RBP-Jκ failed to activate the RBP-Jκ protein. The mutant
further inhibited the function of a constitutively active Notch
mutant (Figure 4). Moreover, as an extension to our previous publication, the RTA-K152E failed to induce KSHV virion accumulation (Figure 5). Thus, two apparently contradicting properties of RTA-K152E have clearly emerged from
our data: (1) RTA-K152E failed to activate the RBP-Jκ protein; but (2) the mutant had similar capabilities to interact
with RBP-Jκ and furthermore to bind to DNA indirectly via
the interaction. The two properties collectively suggest that
the interaction between RTA and RBP-Jκ and their subsequent DNA binding by the complex were not sufficient for
the initiation of lytic replication of KSHV.
It remains unclear how the mutation in the DNA-binding
domain of RTA had such a profound effect on RTA functions.
Because of the known defect in this mutant, our results might
suggest that direct DNA-binding activity of RTA might be required to convert the RBP-Jκ protein from a repressor into an
activator. Since RTA interacts with many cellular factors (Carroll et al., 2006; Gwack et al., 2001; Gwack et al., 2002; Liang et al., 2002; Liang and Ganem, 2003; Liao et al., 2003;
Wang et al., 2001), it is possible that the K152E mutation affects the binding of an unknown cellular factor. It is also possible that the mutation at the DNA-binding domain (K152E)
has changed RTA conformation from a transcriptional activator into a repressor. Based on the structure and function analysis of RTA (Dourmishev et al., 2003; West and Wood, 2003),
the activation domain is located at the C-terminal region of the
RTA. Thus, it is hard to imagine that a single point mutation at
the N-terminus would affect the C-terminal activation domain.
In summary, this report examined the physical interaction
between RTA and RBP-Jκ with respect to the activation of the
RBP-Jκ protein and the activation of KSHV lytic replication.
Our data demonstrated that the physical interaction between
KSHV RTA and RBP-Jκ and their subsequent DNA binding
by the complex were not sufficient to activate RBP-Jκ and to
induce KSHV lytic replication. Other factor(s), whether it is
the intrinsic property of RTA or its interaction with other cofactors, are predicted to be required for the activation of RBPJκ protein by RTA. These findings have provided a new insight into the structure and functions of RTA.
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